glp 1 microdose side effects Common GLP-1 Weight-loss Microdosing GLP-1 Reviews: Real User
Description
The novel peptide is biased towards GLP-1R agonism versus GCGR with a 3-4 fold reduced potency at the GLP-1R compared to native GLP-1 and around an 8-fold reduced potency at the GCGR compared to native glucagon
Hence, in theory, a worsening or different pattern of hypoglycaemia with octreotide is possible
doi:10.1172/JCI116186 23
This Insight is the fourth in a series on GLP-1s that explored compounding, evidence for expanding on- and off-label uses, and coverage limitations
PMID: 30250193
Both ACC1 and ACC2 contain at least eight sites that undergo phosphorylation
